Research programme: antiviral agents - Schering-Plough/NeoGenesis
Alternative Names: Antivirals research programme - Schering-Plough/NeoGenesisLatest Information Update: 22 Apr 2003
At a glance
- Originator NeoGenesis; Schering-Plough
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 10 Aug 2001 Preclinical development for Viral infections in USA (Unknown route)